首页 | 本学科首页   官方微博 | 高级检索  
     


Comparable survival for pediatric acute myeloid leukemia with poor‐risk cytogenetics following chemotherapy,matched related donor,or unrelated donor transplantation
Authors:Michael J. Kelly MD  MPH  John T. Horan MD  MPH  Todd A. Alonzo PhD  Mary Eapen MD  Robert B. Gerbing MS  Wensheng He MS  Beverly J. Lange MD  Susan K. Parsons MD  MRP  William G. Woods MD
Affiliation:1. The Floating Hospital for Children at Tufts Medical Center, , Boston, Massachusetts;2. Department of Pediatrics, Tufts University School of Medicine, , Boston, Massachusetts;3. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, , Boston, Massachusetts;4. Aflac Cancer Center and Blood Disorder Service, Emory University, , Atlanta, Georgia;5. Department of Preventive Medicine, University of Southern California, , Los Angeles, California;6. Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, , Milwaukee, Wisconsin;7. The Children's Oncology Group, , Arcadia, California;8. Children's Hospital of Philadelphia, , Philadelphia, Pennsylvania;9. Department of Medicine, Tufts University School of Medicine, , Boston, Massachusetts
Abstract:
Keywords:acute myeloid leukemia  chemotherapy  hematopoietic cell transplantation  pediatrics
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号